The GLP-1 Era in Pediatric Obesity Management

Pediatrics Now: Cases Updates and Discussions for the Busy Pediatric Practitioner

The GLP-1 Era in Pediatric Obesity Management

Link for CME Credit:

https://cmetracker.net/UTHSCSA/Publisher?page=pubOpen#/getCertificate/10098095

Join host Holly Waymentin this informative episode of Pediatrics Now, as we dive into the latest updates from the Pediatric Grand Rounds. Pediatric Endocrinologist Elia Escaname, MD shares invaluable insights into obesity management and prevention strategies, highlighting the groundbreaking advancements in endocrinology for treating type 2 diabetes and obesity.

Explore the era of GLP-1 receptor agonists, a promising option for managing childhood obesity and type 2 diabetes. Learn about the intricate considerations in diagnosing childhood obesity, how BMI is utilized, and the importance of comprehensive evaluations including annual health checks.

Gain a deeper understanding of the challenges in treating obesity, from medication approvals to the significance of lifestyle interventions. Discover the pivotal studies on FDA-approved medications for obesity in children and the potential side effects to watch out for.

Dr. Escanme also emphasizes the importance of community resources and the need for a multidisciplinary approach in providing comprehensive care. Hear about Project Power, an inspiring initiative aimed at preventing type 2 diabetes in high-risk youth through lifestyle and nutritional education.

Stay informed with the latest research, challenges, and best practices in pediatric obesity management.